Article Text


P03 The diagnostic value of transient elastography compared to clinical acumen, laboratory tests and ultrasound? Is there added value?
  1. G E Dolman1,
  2. A Ferguson2,
  3. S Harris3,
  4. A M Zaitoun4,
  5. M James2,
  6. S D Ryder2,
  7. G P Aithal2,
  8. I N Guha2
  1. 1Nottingham Digestive Diseases Centre/Biomedical Research Unit
  2. 2Nottingham Digestive Diseases Centre/Biomedical Research Unit, University of Nottingham, Nottingham, UK
  3. 3Public Health Sciences and Medical Statistics, University of Southampton, UK
  4. 4Department of Histopathology, Nottingham University Hospitals NHS Trust


Introduction The diagnostic performance of transient elastography (TE), and other non-invasive biomarkers of fibrosis, is assessed by direct comparison with liver biopsy. However clinical acumen, laboratory tests and ultrasonography are utilised for the assessment of fibrosis in clinical practice.

Aim The aim of this study was to assess the incremental value of elastography compared to routine diagnostic tools.

Method We included consecutive patients with both fibroscan and biopsy data. Patients with decompensated cirrhosis or suboptimal fibroscan readings were excluded (success rate <60% or IQR/median >0.21). Four consultant/attending hepatologists (who were blinded to TE and biopsy results) were asked to assess the severity of fibrosis on the basis of anonymised clinical data. Simple laboratory tests (eg, full blood count, liver function tests and clotting) and ultrasonography for each case were then given to the clinicians to assess the incremental increase in diagnostic performance. One independent pathologist formally assessed the degree of fibrosis on biopsy, which was the reference standard. Receiver Operating Characteristics (ROC) curves were calculated for (1) clinical acumen (2) clinical acumen + laboratory tests + ultrasonography and (3) TE, for the prediction of significant fibrosis (greater or equal to F2) and cirrhosis.

Results 130 patients were enrolled in the study with paired data and a biopsy deemed adequate for staging. The cohort (65% male; mean age 46 years) was of mixed aetiology (15% ALD, 48% chronic viral hepatitis, 24% NAFLD, 24% other). The average biopsy length was 23 mm with 16 portal tracts. The median TE reading was 6.3 (median IQR 0.8 and 100% success rate).

Conclusion There appears to be little additional benefit in AUC performance of transient elastography to diagnose cirrhosis compared to clinical acumen and routinely available tests. There is however incremental diagnostic benefit for the assessment of significant fibrosis. The baseline performance of simple diagnostic tools, which will vary depending on the stage of fibrosis, needs to be accounted for when assessing liver biomarker performance.

Abstract P03 Table 1

AUC performance for the assessment of significant fibrosis and cirrhosis

Statistics from

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.